ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM: 605 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
605
Total FAERS Reports
17 (2.8%)
Deaths Reported
96
Hospitalizations
605
As Primary/Secondary Suspect
2
Life-Threatening
Active Ingredient: ANHYDROUS DEXTROSE\CALCIUM CHLORIDE\MAGNESIUM CHLORIDE\SODIUM CHLORIDE\SODIUM LACTATE ·
First Report: 20210101 · Latest Report: 20250910
What Are the Most Common ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM Side Effects?
#1 Most Reported
Therapeutic product effect increased
91 reports (15.0%)
#2 Most Reported
Muscle spasms
85 reports (14.0%)
#3 Most Reported
Dehydration
68 reports (11.2%)
All ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Therapeutic product effect increased | 91 | 15.0% | 0 | 6 |
| Muscle spasms | 85 | 14.1% | 0 | 5 |
| Dehydration | 68 | 11.2% | 0 | 6 |
| Peritonitis | 41 | 6.8% | 0 | 19 |
| Abdominal pain | 39 | 6.5% | 1 | 18 |
| Hypotension | 29 | 4.8% | 0 | 5 |
| Rash | 28 | 4.6% | 0 | 2 |
| Illness | 25 | 4.1% | 1 | 6 |
| Peritoneal dialysis complication | 25 | 4.1% | 0 | 8 |
| Pruritus | 24 | 4.0% | 0 | 2 |
| Therapeutic product effect decreased | 24 | 4.0% | 0 | 1 |
| Peritoneal cloudy effluent | 23 | 3.8% | 1 | 7 |
| Nausea | 22 | 3.6% | 1 | 8 |
| Vomiting | 22 | 3.6% | 1 | 7 |
| Fluid retention | 21 | 3.5% | 0 | 3 |
| Poor quality product administered | 21 | 3.5% | 0 | 5 |
| Malaise | 19 | 3.1% | 0 | 4 |
| Pain | 19 | 3.1% | 0 | 2 |
| Product container issue | 19 | 3.1% | 0 | 3 |
| Swelling | 18 | 3.0% | 1 | 2 |
Who Reports ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM Side Effects? Age & Gender Data
Gender: 44.0% female, 56.0% male. Average age: 61.7 years. Most reports from: US. View detailed demographics →
Is ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2021 | 3 | 0 | 0 |
| 2022 | 119 | 6 | 18 |
| 2023 | 114 | 4 | 25 |
| 2024 | 62 | 1 | 9 |
| 2025 | 39 | 1 | 6 |
What Is ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM Used For?
| Indication | Reports |
|---|---|
| Peritoneal dialysis | 185 |
| End stage renal disease | 78 |
ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM vs Alternatives: Which Is Safer?
ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM vs APALUTAMIDE
ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM vs APIXABAN
ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM vs ARANESP
ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM vs ARGATROBAN
ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM vs ARIPIPRAZOLE
ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM vs ASPIRIN
ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM vs ASPIRIN DL-LYSINE
ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM vs ATENOLOL
ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM vs ATEZOLIZUMAB
ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM vs ATORVASTATIN
Official FDA Label for ANHYDROUS DEXTROSE\CALCIUM\MAGNESIUM\SODIUM\SODIUM
Official prescribing information from the FDA-approved drug label.